Huma Therapeutics, formerly Medopad, has unveiled its strategic collaboration with Google Cloud to integrate generative AI (GenAI) into its regulated disease management platform. By leveraging Google Cloud's Vertex AI platform and exploring tools like Med-PaLM 2, specialized for the medical domain, Huma aims to support healthcare professionals (HCPs) in delivering optimized care.
With the rising demands on the healthcare workforce, Huma's technology platform captures vital signs, biomarkers, and patient-reported data, enabling efficient remote patient monitoring and expanding access to healthcare services. By automating the generation of clinical reports and surfacing relevant information, GenAI enhances the documentation and triaging processes, allowing HCPs to focus on patient-centric care. Moreover, GenAI facilitates predictive, personalized care by harnessing real-world data insights, ultimately benefiting health systems and patients. Additionally, GenAI aids in improving patient engagement by streamlining communication between patients and providers, leading to individually tailored care plans and enhanced patient experiences. Emphasizing a "human in the loop" approach, Huma ensures that qualified healthcare professionals validate and adjust AI outputs, maintaining control and safety in healthcare technologies. This collaboration underscores Huma's commitment to making healthcare accessible and affordable while driving better care delivery and outcomes through innovative AI solutions.
0 Comments
Leave a Reply. |
AuthorHilt Tatum is CEO of Oxford Consulting Group - International business consulting Archives
December 2019
Categories
All
|